Aktienmarkt
Grifols prepares stock listing for its US Biopharma business
Von KI berichtet Bild generiert von KI
Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.
Der Ibovespa legte am Montag (23.) um 3,24 % zu und erreichte 181.900 Punkte, angetrieben von den Äußerungen Donald Trumps zu Gesprächen zwischen den USA und dem Iran. Brent-Öl fiel um 9,6 % auf 96,3 USD, und der Dollar sank auf 5,23 R$.
Von KI berichtet
South Korean shares opened sharply lower on March 19 amid attacks on Middle East energy facilities during the US- and Israel-led war against Iran. The US Federal Reserve's decision to keep rates unchanged further dampened sentiment. The KOSPI fell 2.16% in the first 15 minutes.